What condition is Breo Ellipta (fluticasone furoate/vilanterol) used to treat?
Breo Ellipta is used to help control symptoms of chronic lung diseases by reducing airway inflammation and opening airways. It’s prescribed for:
- Chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, to reduce flare-ups (exacerbations) and improve breathing.
- Asthma, to help prevent symptoms and reduce the risk of flare-ups in people who need maintenance treatment with an inhaled corticosteroid plus a long-acting bronchodilator.
What does it do in the body (and why that matters for use)?
Breo Ellipta combines two medicines:
- Fluticasone furoate (an inhaled corticosteroid) treats the inflammatory component of airway disease.
- Vilanterol (a long-acting beta2-agonist, LABA) relaxes airway muscles to keep airways open.
Because it’s a maintenance inhaler, it’s intended for regular daily control, not for rapidly stopping an asthma or COPD attack as it starts.
Is Breo Ellipta for quick relief during breathing trouble?
No. Breo Ellipta is not meant to replace a rescue inhaler (like a short-acting bronchodilator) for sudden symptoms. If symptoms come on suddenly or a rescue inhaler is needed more often, that can be a sign the treatment plan needs review.
Who typically gets Breo Ellipta instead of just an inhaled steroid?
Doctors commonly use Breo Ellipta when:
- Inhaled steroid alone isn’t enough for control, or
- Symptoms persist and a long-acting bronchodilator is needed for better day-to-day control and fewer exacerbations.
Common patient question: when should it be taken?
Breo Ellipta is usually taken once daily, following the prescribed schedule. Consistent use matters because it works to control chronic inflammation and maintain airway opening over time.
Sources:
No sources were provided in the prompt.